Washout Rate of Tc-99m MIBI in Bone and Soft-tissue Sarcomas Muhammad Sohaib

Neoadjuvant therapy is employed before the primary treatment of sarcomas. It is not uncommon that it fails due to multi-drug resistance gene causing unnecessary delays in surgery. Tc-99m MIBI, a radiopharmaceutical, is taken-up in these tumours. Being Это и многое другое вы найдете в книге Washout Rate of Tc-99m MIBI in Bone and Soft-tissue Sarcomas (Muhammad Sohaib)